Immunic, Inc.
IMUX
$0.8293
-$0.0229-2.69%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -101.84M | -96.40M | -100.51M | -96.90M | -95.31M |
| Total Depreciation and Amortization | 163.00K | 151.00K | 134.00K | 122.00K | 114.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 8.12M | 7.73M | 15.39M | 14.73M | 14.50M |
| Change in Net Operating Assets | 3.40M | 5.94M | 214.00K | 6.22M | 8.35M |
| Cash from Operations | -90.15M | -82.58M | -84.77M | -75.84M | -72.35M |
| Capital Expenditure | -136.00K | -280.00K | -264.00K | -426.00K | -420.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 0.00 | 0.00 |
| Cash from Investing | -136.00K | -280.00K | -264.00K | -426.00K | -420.00K |
| Total Debt Issued | 0.00 | 0.00 | 74.27M | 74.27M | 74.27M |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 65.60M | 83.00K | 274.00K | 795.00K | 1.08M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -6.00K | -6.00K | -6.00K | -- | -- |
| Cash from Financing | 65.60M | 77.00K | 74.54M | 75.07M | 75.35M |
| Foreign Exchange rate Adjustments | 304.00K | -224.00K | -509.00K | 578.00K | -179.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -24.39M | -83.01M | -11.01M | -618.00K | 2.40M |